Skip to main content
Caplight Logo









Chebigen Co., Ltd.

Chebigen Co., Ltd.

Private
Jeonju-siHealthcare & Life Scienceshttps://chebigen.com/

Last Round

Grant

Jul 9, 2024

Company Overview

Chebigen Co., Ltd. is a biotechnology company that specializes in the development of functional probiotic and postbiotic ingredients, liposome/capsule delivery technologies, and natural extracts for health supplements and pharmaceutical applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

probioticspostbioticsnutraceutical ingredientsmicro-encapsulationCMOcontract manufacturing organizationODMOEMwhite label supplementsgut healthbioconversionmicrobiome researchNGSnext-generation sequencingbioinformatics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Chebigen Co., Ltd. Comparables

Compare Chebigen Co., Ltd. with similar companies based on industry and business-model similarity.

No public comparables are available for Chebigen Co., Ltd.. Request access to learn about comparables coverage.

Request access

Chebigen Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 9, 2024
GrantMay 16, 2022
GrantDec 23, 2020
GrantOct 11, 2019

Chebigen Co., Ltd. Investors

Notable investors and investment history

Chebigen Co., Ltd. investors
InvestorRounds
Korea Institute for Advancement of TechnologyGrant
Government of South KoreaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 9, 2024

    Received grant funding from the Government of South Korea.

  • May 16, 2022

    Received grant funding from the Government of South Korea.

Chebigen Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Chebigen Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Chebigen Co., Ltd.'s valuation, stock price, and market status.

Is Chebigen Co., Ltd. a public or private company?

Chebigen Co., Ltd. is a private company.

What is the current stock price of Chebigen Co., Ltd.?

Chebigen Co., Ltd. is a private company with no public stock price. Caplight tracks Chebigen Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Chebigen Co., Ltd. worth (valuation)?

Valuation information for Chebigen Co., Ltd. is not publicly available.

Can I buy Chebigen Co., Ltd. stock?

Chebigen Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Chebigen Co., Ltd.'s last funding round?

Chebigen Co., Ltd.'s most recent funding round was Grant on July 9, 2024.

Who are the main investors in Chebigen Co., Ltd.?

Key investors in Chebigen Co., Ltd. include Korea Institute for Advancement of Technology, Government of South Korea.

Will Chebigen Co., Ltd. IPO soon?

No public IPO plans have been announced for Chebigen Co., Ltd..

How can I track Chebigen Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Chebigen Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersJeonju-si
Year Founded2000
Last FundingJul 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?